Aphria Inc (TSX:APHA) Is Sinking Fast: Is Now the Time to Buy Low?

Nothing earthshaking happened when Aphria (TSX:APHA)(NYSE:APHA) reported its latest quarterly earnings, except for the sharp drop in the stock price. That pattern has been same whenever cannabis producers present their earnings results. Every story is predictable — whopping revenues and a mountain of losses. For the first time, Aphria’s earnings results included a full quarter of adult-use sales. APHA sunk…

Read More

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) Surges 45% After Signing LOI with Pharmascience, Inc.

Pivot Pharmaceuticals, Inc.

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) is a biopharmaceutical company focused on the development and commercialization of cannabis-based therapeutic pharmaceuticals, nutraceuticals, and drug delivery platform technologies. The company’s U.S.-listed shares surged 44.79% on Wednesday, April 3, 2019. Over the past month, Pivot has seen an average daily volume of 24,550 shares. However, on Wednesday, 239,787 shares traded hands, equating…

Read More